Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.51 $0 (0%) RKDA stock closing price Jul 21, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Arcadia Biosciences stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Arcadia Biosciences stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Arcadia Biosciences balance sheet as at the end of 2016 indicates an asset turnover ratio of 0.08M and debt to equity ratio of 1.37M. Whereas, Arcadia Biosciences revenue was $3.18M and Arcadia Biosciences operating cash flow was $-17.05M for the same period. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Fiscal year is Jan - Dec. 2016 2015 2014 2013
Marketable Securities48.54M26.27M--
Raw Materials----
Work In Progress----
Finished Goods----
Notes Receivable----
Other Current Assets0.87M0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
Property Plant & Equipment5.44M5.24M5.38M5.27M
Accumulated Depreciation4.94M4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances2.49M19.74M0.5M1.43M
Other Non-Current Assets1.32M1.86M2.14M2.53M
Deferred Charges----
Deposits & Other Assets0.01M0.02M2.81M0.06M
Arcadia Biosciences Total Assets
Notes Payable--5.6M4.56M
Accounts Payable2.35M2.42M3.19M2.51M
Current Portion Long-Term Debt----
Current Portion Capital Leases----
Accrued Expenses----
Income Taxes Payable----
Other Current Liabilities0.77M1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income3.12M2.63M3.63M4.37M
Convertible Debt----
Long-Term Debt25.12M24.93M8.86M9.92M
Non-Current Capital Leases----
Other Long-Term Liabilities3M3M3M3M
Arcadia Biosciences Total Liabilities
Minority Interest----
Preferred Stock--82.88M-
Common Stock Net0.04M0.04M--
Capital Surplus173.72M172.22M29.2M78.33M
Retained Earnings-151.55M-131.92M-113.97M-95.63M
Treasury Stock----
Other Liabilities-0.01M-0.11M--
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

Apart from balance sheet items, an investor would do well to keep track of the Arcadia Biosciences stock price by looking at Arcadia Biosciences historical stock prices. One can compare PE with industry average by looking at the Arcadia Biosciences PE ratio chart. The common balance sheet items are:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has monetary significance. RKDA assets decreased from $74.24M in 2015 to $56.57M in 2016 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Arcadia Biosciences's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for RKDA stock stand at $34.37M.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio